Clinical Trial

Optical Genome Mapping in Hematological Malignancies

Name: Optical Genome Mapping in Hematological Malignancies — clinical trial record (NCT05009537)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CARTOGEN

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated August 17, 2021 (before its estimated September 2022 completion). Its status may not reflect the trial's current state.

Summary

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

Trial Details

NCT Number	NCT05009537
Lead Sponsor	University Hospital, Brest
Conditions	MDS, ALL, Other Hematologic Malignant Neoplasms
Enrollment	200 participants
Start Date	2021-09
Primary Completion	2022-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2021-08-17